Primary care patients' use of conventional and complementary medicine for chronic low back pain. by Rodondi, P.Y. et al.
OR I G I N A L R E S E A R C H
Primary care patients’ use of conventional and
complementary medicine for chronic low back
pain
This article was published in the following Dove Press journal:
Journal of Pain Research
Pierre-Yves Rodondi1,2
Anne-Sylvie Bill1
Nadia Danon3
Julie Dubois1,2
Jérôme Pasquier1
Florence
Matthey-de-l'Endroit1
Lilli Herzig1
Bernard Burnand1
1Center for Primary Care and Public
Health (Unisanté), University of
Lausanne, Lausanne, Switzerland;
2Institute of Family Medicine, University
of Fribourg, Fribourg, Switzerland; 3Pain
Center and Center for integrative and
complementary medicine, Department of
Anesthesiology, Lausanne University
Hospital and Faculty of Biology and
Medicine, University of Lausanne,
Lausanne, Switzerland
Purpose: To investigate among primary care patients and their physicians in western
Switzerland the prevalence of use, perceived usefulness, and communication about common
treatments for chronic or recurrent low back pain (crLBP) including complementary medi-
cine (CM).
Patients and methods: A cross-sectional cluster observational study involving 499 crLBP
patients visiting 45 primary care physicians (PCPs) was conducted from November 1, 2015,
to May 31, 2016. Patients and primary care physicians completed questionnaires about
lifetime use and usefulness of 30 crLBP therapies. We conducted multivariate analyses of
factors associated with therapy use, including sociodemographic variables, pain duration,
insurance coverage, and primary care physicians’ characteristics.
Results: The ﬁve most frequent modalities used at least once by patients were physiotherapy
(81.8%), osteopathic treatment (63.4%), exercise therapy (53.4%), opioids (52.5%), and
therapeutic massage (50.8%). For their PCPs, the ﬁve most useful therapies were physiother-
apy, osteopathic treatment, yoga, meditation, and manual therapy. In multivariate analysis,
the use of physiotherapy was signiﬁcantly associated with longer pain duration; osteopathic
treatment was associated with age under 75 years, female gender, higher education, and CM
insurance coverage. Exercise therapy was associated with non-smoking and longer pain
duration. Smokers were more likely and patients of PCPs with CM training were less likely
to have used opioids. During their lifetime, 86.6% of the participants had used at least one
CM therapy to manage their crLBP, with a mean of 3.3 (SD=2.9) therapies used per
participant; 46.1% of participants reported that their PCP did not enquire about CM use.
Among CM users, 64.7% informed their PCP about it.
Conclusion: Patients with crLBP use a variety of treatments, including self-prescribed and
unreimbursed therapies, most frequently physiotherapy and osteopathy. The results suggest
that PCPs should systematically discuss with their patients the treatments they tried to
manage crLBP, including CM.
Keywords: chronic low back pain, lifetime use, treatments
Introduction
Low back pain (LBP) affects individuals of all ages and is considered to cause more
years lived with disability than any other health condition worldwide.1,2 The
contribution of LBP to disability is likely to increase in the context of the aging
population.1 While the vast majority of LBP episodes resolve within 2–4 weeks, a
third of patients will experience recurrent episodes within 1 year or chronic LBP,
the prevalence of which is increasing.3–5 Unfortunately for this population, coping
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with back pain might be a lifetime challenge6 and these
recurrent episodes and chronic cases are responsible for
most of the health expenses related to LBP.7 In addition,
the intensity of LBP can vary in individuals over time
without any active treatment.
The number of therapies available to manage chronic
or recurrent LBP (crLBP) is broad, ranging from surgery
to pharmacotherapy and to non-pharmacological
treatments.8,9 The effectiveness and safety of pharma-
cotherapy has, however, been challenged, including the
use of acetaminophen, NSAIDs, anticonvulsants (eg, gaba-
pentin, pregabalin), and opioids.10–14 On the other hand,
evidence is emerging regarding the beneﬁts of some non-
pharmacological or complementary medicine (CM) treat-
ments to improve crLBP outcomes. CM is deﬁned as a
group of diverse medical and health-care systems, prac-
tices, and products that are not generally considered part of
conventional medicine.15
Indeed, recent studies have shown beneﬁcial effects of
yoga,16 acupuncture,17 osteopathic treatment,18 hypnosis,19
Taï chi,20 therapeutic massage,21 and exercise therapy22 for
crLBP.
Given these recent ﬁndings, in 2017, the American
College of Physicians shifted its guidelines for crLBP man-
agement by recommending as ﬁrst-line options non-phar-
macological therapies, including exercise (pain and
function: small effect, moderate-quality evidence), acupunc-
ture (pain and function: moderate effect, moderate-quality
evidence), mindfulness-based stress reduction (pain and
function: small effect, moderate-quality evidence), tai chi
(pain: moderate effect, low-quality evidence; function:
small effect, low-quality evidence) and yoga (pain and
function: small to moderate effect, low-quality evidence),
and recommending pharmacological treatment, like
NSAIDs (pain: small effect, moderate-quality evidence;
function: small effect, low-quality evidence) only following
an inadequate response to ﬁrst-line non-pharmacological
interventions.23 However, this recommendation is based
on moderate-quality evidence and most of the data on
these therapies have only shown short-term effects.
CrLBP is a frequent reason for patients to seek phy-
siotherapy, exercise therapy, and CM.24,25 In Switzerland,
the lifetime prevalence of CM use for crLBP among
patients consulting at a tertiary pain center was 77.3%,26
with osteopathic treatment, therapeutic massage, and acu-
puncture being the most frequently used therapies.
Acupuncture, homeopathy, herbal medicine, hypnosis,
Chinese herbs, and anthroposophic medicine are
reimbursed by mandatory basic health insurance in
Switzerland if provided by a physician. In addition, there
are four main groups of manipulative therapies in
Switzerland, provided by four different professions with
speciﬁc training: manual medicine provided by trained
physicians, chiropractic by chiropractors, physiotherapy
by physiotherapists, and osteopathy by osteopaths.
Manual therapy and chiropractic are reimbursed by man-
datory basic health insurance, as well as physiotherapy if
prescribed by a physician. Osteopathy and all other CM
therapies require supplementary insurance in order to be
covered (see Table 3, second column for insurance
coverage).27 In 2012, about 60%28 of the Swiss population
had supplementary health insurance for CM. Many differ-
ent supplementary health insurance schemes are available
in Switzerland, and the offer is heterogeneous across
health insurance companies. Since CM that is not covered
by basic health insurance does not require a medical pre-
scription, access to most forms of CM is self-prescribed
and consumption of CM services is not available in routine
statistics. The concomitant use of CM and conventional
medicine is frequent in Switzerland29 and in the US,
especially for LBP.25,26 A recent meta-analysis revealed a
33% disclosure rate for biologically based CM.30 Reasons
for non-disclosure often included the patients’ fear to be
disapproved by their physician, or the fact that the physi-
cian did not ask. Reasons for disclosure often included the
fact that the physician asked. The authors of this review
concluded that disclosure of CM use to physicians should
be encouraged to improve the safety and effectiveness of
patient care. The disclosure rate of CM use for crLBP has
been estimated at a Pain center (47%),26 but it is not
known in private practice in Switzerland.
To the best of our knowledge, no population-based
studies have speciﬁcally examined the use of a diversity
of treatments for the management of crLBP in primary
care. Thus, we aimed to provide insights into the use of a
wide range of treatments for crLBP, including a detailed
list of CM therapies, independently of whether they had
been prescribed by a physician and the patient had been
reimbursed. Our main objective was to assess the preva-
lence of use of the most common crLBP treatments by
primary care patients and to describe perceived usefulness
of both patients and their primary care physicians (PCPs)
in western Switzerland. Furthermore, we explored asso-
ciated variables with therapies used for crLBP. Our sec-
ondary objective was to describe PCP-patient
communication about CM use for crLBP management.
Rodondi et al Dovepress
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Methods
Study design
This cross-sectional study was conducted in a series of
primary care practices of the western French-speaking part
of Switzerland from November 1, 2015, to May 31, 2016.
PCPs recruited consecutive consenting patients with
crLBP during regular medical visits (Figure 1).
Setting and participants
PCPs were recruited from small or large practices in
both urban and rural settings, in the different regions of
the French part of Switzerland. The enrolled physicians
completed and returned the paper questionnaire, which
was an inclusion criterion for enrolling participants in
the study. Eligible participants had crLBP, were 18
years of age or more, and were able to read and under-
stand French. CrLBP was deﬁned as pain lasting or
recurring for 3 months or more31 and recurring LBP
was deﬁned as ≥2 episodes of LBP during the previous
year, with a signiﬁcant impact on the patient’s daily
life.
During the study period, the PCP screened each visit-
ing patient for the presence of crLBP, regardless of the
reason for consultation, and handed out the questionnaire
to 30 consecutive eligible patients. Patients were asked to
complete the questionnaire at home and to return it in the
prestamped envelope to the research team. Patients were
entirely anonymous to the research team. Participation to
the survey was voluntary. For each physician, the study
ended after they had distributed 30 patient questionnaires
or after 4 months following the recruitment of the ﬁrst
patient. As the questionnaires were anonymous, no
informed consent had to be signed. By ﬁlling out the
survey, participants gave implied consent. The study pro-
tocol and the questionnaires were approved by the com-
mittee on medical research ethics of the Canton of Vaud
(ID Nb. 303/15).
Invited PCPs
n = 60
STEP II
Inclusion of patients
Returned questionnaires
n = 48
Returned questionnaires
n = 514
Final sample
n = 499 (37.0%)
Noneligible
n = 15
Final PCP sample
n = 45
Potential study
participants (patients)
n = 1350 (100%)
Nonresponders
n = 12
Dropouts
n = 3
STEP I
Inclusion of primary care
physicians
Figure 1 Flow chart of study participants.
Abbreviation: PCP, primary care physicians.
Dovepress Rodondi et al
Journal of Pain Research 2019:12 submit your manuscript | www.dovepress.com
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Sample size calculation
For the sample size estimation, we relied on the 59%
prevalence of CM use for cLBP according to US data.25
Given the cluster (physician) design of the study, we used
an intracluster correlation of 0.03. In order to get a 5%
width CI around the estimate, the number of patients
needed amounted to 480.
Development of the questionnaire
The patient and the PCP questionnaires were based on
previously published instruments.26,32,33 Questionnaires
are provided in the supplementary material 1 and 2. Both
questionnaires were cognitively tested. This test aimed to
assess how respondents understood the intent and meaning
of survey items and whether their answers agreed with the
interpretations of the researchers. A convenience sample
of 10 volunteer crLBP patients and 10 healthy volunteers
from the general population with a wide range of socio-
demographic features took part in the cognitive interviews.
The 10 volunteer patients with crLBP did not take part in
the study. Amendments were made to the questionnaire to
improve comprehension of the survey items. We evaluated
the stability of the questionnaire by means of a test–retest
reliability procedure. Seven patients were asked if they
would agree to provide their postal address in order to
send them the same questionnaire 2 weeks after we had
received their ﬁrst-completed questionnaire. Although the
seven patients completed the retest, the number of partici-
pants was too low to perform a concordance or reliability
measurement by item. However, we observed a mean
agreement of 87% between the ﬁrst and the second
questionnaire.
Variables
We developed two questionnaires. The patients question-
naire that was divided into several sections, which explored
the following: 1) sociodemographic and lifestyle data, 2)
duration and burden of LBP, 3) pain interference with
normal activities and functional status, and 4) patients’
lifetime use and perception of usefulness of 30 therapies
speciﬁcally for crLBP, 21 of which were CM therapies.
Therapies chosen for the questionnaire were based on the
potentially most used therapies according to different fac-
tors: prevalence of use, reimbursement by the Swiss health-
care system or scientiﬁc evidence. All therapies considered
as CM in the present study are indicated with a superscript
letter in Table 3. As recommended in the report of the
National Institutes of Health task force on research stan-
dards for crLBP,34 we used the research task force impact
classiﬁcation scoring tool to determine the impact of crLBP
on respondents’ daily life. PROMIS (Patient Reported
Outcomes Measurement Information System) scores for
pain intensity, physical function, and pain interference34,35
were part of this measurement tool. Current smoking was
assessed with the question: “Do you currently smoke, even
occasionally?” (answer: yes/no).36,37 The PCP questionnaire
was divided into 4 sections exploring: 1) socio-demographic
data, 2) PCPs’ perception of usefulness of 25 therapies
speciﬁcally for crLBP, 23 of which were CM therapies,
and their reported prescribing behavior, 3) PCPs’ perceived
usefulness of CM in general and of speciﬁc CM treatments
and their recommendations, and 4) PCP’s attitude towards
use of CM.
Statistical analysis
Statistical analyses were performed using R version 3.5.0.
We considered that missing values occurred completely at
random and proceeded to complete cases analyses. Results
were expressed as means (SD) or as percentages.
Intraclass correlation coefﬁcients (ICC) were calculated
for Tables 3 and 4 in order to quantify the cluster effect.
ICC are estimated using mixed models. ICC is deﬁned as
the ratio of between-cluster variance to total variance. The
variances are estimated using regression model with ran-
dom intercept and no other predictors. Multivariate analy-
sis was performed using logistic regression and results
were expressed as OR and 95% CI. We performed multi-
variate analyses for the therapies used by at least 20% of
participants. The response variable was the use or not of
the therapy and the explicative variables were patients’
age, gender, education, smoking habits, pain duration,
CM insurance coverage, the PCPs’ gender, age, and train-
ing in CM. These explicative variables were selected
because they were often associated with therapy use in
other studies.25,26,38 Since the ICC were not negligible in
univariate analyses, a random effect was considered to
take account of the cluster design.39
Results
Response rate
Of 149 PCPs contacted, 60 agreed to participate and 45
eventually did (Figure 1). A total of 514 completed patient
questionnaires were returned, 15 of which could not be
included because the two PCPs associated with the
Rodondi et al Dovepress
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patients did not return their own questionnaire. Thus, the
patient response rate was 37% (499 of 1350). Selected
sociodemographic characteristics are summarized in
Table 1. Over half of the participants (n=272, 55%) were
unemployed, most of these being retired (n=205, 75%).
LBP characteristics
Pain characteristics are presented in Table 2. For most
participants, crLBP had been an ongoing problem for >5
years. Almost a third of the participants experienced severe
LBP and half experienced moderate LBP in the 6 months
before completing the questionnaire. Half of the participants
had experienced LBP every day or nearly every day during
the 6 months before completing the survey. The impact
score of LBP on daily living was rated as moderate or
severe by 79.2% of study participants.
Therapies used to manage crLBP
The top 5 therapies used by patients for crLBP during
their lifetime were physiotherapy, followed by osteo-
pathic treatment, exercise therapy, opioids and therapeu-
tic massage (Table 3). Overall, the mean number of
different therapies used by each participant was 6.5
(SD=3.9). Table 3 shows which treatments are reim-
bursed by basic or CM health insurance in
Switzerland. The therapies most often used by patients
are not always reimbursed by basic health insurance
coverage. Among the top 5 therapies used to relieve
crLBP during a patient’s lifetime, no medical prescrip-
tion is required for osteopathic treatment and therapeutic
massage. Among the therapies used by at least 20% of
participants (ie, 11 therapies), the ﬁve therapies rated by
the patients (who used those therapies) as being most
helpful for this condition were osteopathic treatment,
opioids, manual therapy, physiotherapy, and exercise
therapy. Among these 11 frequently used therapies,
only homeopathy received a mean perceived usefulness
score under 5 points (on a 0–10 visual analog scale)
according to the patients. Among 25 therapies, the ﬁve
Table 1 Patients’ socio-demographic characteristics (N=499)
Variable n (%)
Age, mean (SD) 59.6 (15.3)
Sex (n=496/499)
Male
Female
162 (32.7)
334 (67.3)
Origin (n=492/499)
Swiss
Other
426 (86.6)
66 (13.4)
Educational level (n=492/499)
Basic (until college)
Apprenticeship
University, professional diploma/high school
90 (18.3)
180 (36.6)
222 (45.1)
Living status (n=496/499)
Single
Single with children
In a relationship with children
In a relationship without children
Other
139 (28.0)
31 (6.3)
120 (24.2)
179 (36.1)
27 (5.4)
Current smoking (n=499/499)
Yes 116 (23.2)
No 383 (76.8)
Health coverage of CM (n=489/499)
Yes
No
Unknown
326 (66.7)
123 (25.2)
40 (8.2)
Notes: Results are expressed as number of participants (percentage) except where
otherwise indicated. Since the participants ﬁlled in the paper questionnaires at
home, some answers were not completed by all of them and had to be omitted.
Therefore, the total n for each question varies. The number and percentage of
missing answers for each question does not exceed n=10/499, that is 2.0%.
Abbreviation: CM, complementary medicine.
Table 2 Participants’ pain characteristics (N=499)
Pain characteristics n (%)
Pain frequency in the past 6 months (n=484/499)
Every day or almost every day 243 (50.2)
Every other day 89 (18.4)
Less than every other day 114 (23.6)
No pain in the past 6 months 38 (7.9)
Duration of paina (n=467/470)
<1 year 61 (13.1)
≥1 to <5 years 116 (24.8)
≥5 years 290 (62.1)
Pain intensity in the past 6monthsa,b (n=450/470)
Mild (1–3) 82 (18.2)
Moderate (4–6) 235 (52.2)
Severe (7–10) 133 (29.6)
RTF impact classiﬁcation scorea,c (n=453/470)
Mild (8–27) 94 (20.8)
Moderate (28–34) 222 (49.0)
Severe (35–50) 137 (30.2)
Notes: Results are expressed as number of participants (percentage).
aAmong the 499 study participants, 29 “without any pain currently” were excluded
from these subgroups. Since the participants ﬁlled in the paper questionnaires at
home, some answers were not completed by all of them and had to be omitted.
Therefore, the total n for each question varies. The number and percentage of
missing answers for each question does not exceed n=20/470, that is 4.3%.
bPain intensity was calculated on a 0–10 visual analog pain scale.
cThe research task force (RTF) impact classiﬁcation score ranges from 8 (least
impact) to 50 (greatest impact).
Dovepress Rodondi et al
Journal of Pain Research 2019:12 submit your manuscript | www.dovepress.com
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therapies rated as being most useful according to PCPs
were physiotherapy, osteopathic treatment, yoga, medi-
tation, and manual therapy. Regarding the group of
therapies considered as CM speciﬁcally, 86.6% of the
participants had used at least one of them to manage
their crLBP during their lifetime, with a mean of 3.3
(SD=2.9) CM therapies used per participant. In the pre-
vious 12 months, 61.1% of participants reported any
CM use for crLBP.
Multivariate analysis
In the continuity of the primary objective, we identiﬁed the
factors associated with therapies used for crLBP by at least
20% of the participants during their lifetime. Table 4
shows the multivariate analysis of participants’ consump-
tion patterns for those therapies, adjusted for patients’ age,
gender, education, current smoking, pain duration, and CM
insurance coverage, as well as for PCPs gender, age, and
training in CM. Except for osteopathic treatment, which
Table 3 Lifetime use of assessed therapies and their perceived usefulness in crLBP management (minimal number of responses for
therapy, n=485)
Therapy Insurance
coverage
Participants
(n=499)
ICC Perceived
usefulness
ICC PCPs (n=45)
Use Agreeing about
usefulness
n (%) Mean (SD)
Physiotherapy Basic 405 (81.8) 0.139 6.0 (2.6) 0.001 44 (97.8)
Osteopathic treatmenta CMI 312 (63.4) 0.068 6.7 (2.5) 0.085 42 (93.3)
Exercise therapy Basic 261 (53.4) 0.012 6.0 (2.7) 0.100 Missing
Opioids Basic 244 (52.5) 0.074 6.3 (2.6) <0.001 31 (68.9)
Therapeutic massagea CMI 249 (50.8) 0.059 5.9 (2.5) <0.001 37 (82.2)
Spinal/nerve block Basic 163 (33.6) 0.031 5.2 (3.5) <0.001 Missing
Acupuncturea Basic 155 (31.3) 0.023 5.1 (3.0) <0.001 33 (73.3)
Chiropractic treatment Basic 148 (30.1) 0.002 5.5 (2.7) 0.004 31 (68.9)
Traditional healinga CMI 143 (28.9) 0.054 5.5 (2.6) 0.059 23 (51.1)
Manual therapy Basic 110 (22.7) 0.132 6.2 (2.6) <0.001 38 (84.4)
Homeopathya Basic or CMI 107 (22.0) 0.110 4.4 (2.5) 0.294 15 (33.3)
Reﬂexologyb CMI 74 (15.0) 0.060 5.0 (2.4) 0.229 22 (48.9)
Aromatherapya CMI 73 (14.8) 0.035 5.1 (2.7) 0.265 3 (6.7)
Yogab CMI 70 (14.2) 0.102 5.3 (2.8) <0.001 40 (88.9)
Magnetisma CMI 70 (14.1) <0.001 5.1 (2.8) 0.061 29 (64.5)
Kinesiologya CMI 63 (12.8) <0.001 5.3 (2.8) 0.042 12 (26.3)
Meditationa – 56 (11.4) <0.001 5.2 (2.4) <0.001 38 (86.4)
Herbal medicinea Basic or CMI 49 (10.0) 0.127 4.8 (2.5) 0.119 20 (44.5)
Psychological advice Basic or CMI 49 (10.1) 0.063 5.5(2.9) <0.001 Missing
Reikia CMI 44 (8.9) <0.001 5 (2.8) 0.362 9 (20.0)
Low back surgical
intervention
Basic 61 (12.3) 0.120 7.1 (3.1) <0.001 Missing
Sophrologya CMI 37 (7.4) 0.047 4.9 (2.1) <0.001 35 (78.0)
Shiatsua CMI 31 (6.3) 0.141 5.4 (2.6) 0.307 24 (53.3)
Tai chi and/or qi gonga CMI 26 (5.3) 0.087 5.5 (2.9) <0.001 32 (71.1)
Hypnosisa Basic or CMI 24 (4.8) 0.043 4.6 (2.4) 0.000 35 (77.8)
Ayurvedic medicinea CMI 19 (3.8) <0.001 4.1 (2.5) 0.468 11 (24.4)
Chinese herbsa Basic 18 (3.6) <0.001 3.4 (3.0) 0.902 9 (20.0)
Art therapya CMI 7 (1.4) <0.001 6.9 (2.7) 13 (28.9)
Anthroposophic
medicinea
Basic or CMI 2 (0.4) <0.001 0 (0.0) 5 (11.1)
Notes: –, no insurance coverage. aIndicates therapies considered to be complementary medicine in the present study.
For each treatment, data shown include the proportion of participants having used it in their lifetime (column 3), the perceived usefulness rated on a 0–10 visual analog pain
scale (0 being useless and 10 being extremely useful, column 5), and the proportion of PCPs who agree or strongly agree with its usefulness (column 7). For clarity, the
number of missing answers are not given (but available on request).
Abbreviations: crLBP, chronic low back pain; PCP, primary care physician; basic, mandatory basic health insurance; CMI, complementary medicine health insurance if
provided by an afﬁliated therapist; ICC, intraclass correlation coefﬁcient.
Rodondi et al Dovepress
submit your manuscript | www.dovepress.com
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was used signiﬁcantly more often by women, patient gen-
der was not associated with the consumption of any ther-
apy. Older age of patients (≥75 years) was negatively
associated with the use of osteopathic treatment and tradi-
tional healing. A higher education was signiﬁcantly asso-
ciated with increased use of osteopathic treatment for
crLBP. Current smoking was associated with signiﬁcantly
greater odds of having used opioids and signiﬁcantly lower
odds of having followed exercise therapy for crLBP.
Respondents having experienced crLBP for >5 years
were more likely to have resorted to physiotherapy, exer-
cise therapy, spinal/nerve block, chiropractic treatment,
traditional healing, and manual therapy than were respon-
dents having experienced crLBP for <5 years.
Respondents having CM insurance coverage were more
likely to have used osteopathic treatment and chiropractic
treatment for crLBP. Neither the PCPs’ age nor their
gender was signiﬁcantly associated with patients’ lifetime
use of any therapy. Participants visiting a PCP who had
training in CM were signiﬁcantly less likely to have
resorted to opioids during their lifetime to manage crLBP.
Patient-PCP communication
Regarding communication, 46.1% of the participants
reported that their PCP did not enquire about their CM
use. Among patients using CM (n=465), 64.7% sponta-
neously informed their PCP about their CM use. Among
all patients, 42.7% reported that the PCP advised CM as a
treatment option for crLBP. Most patients (80.4%) would
be likely or very likely to try CM if their PCP offered such
a treatment option.
Discussion
Patients with crLBP who visited their PCPs used a wide
range of therapies, not always covered by basic health
insurance, to manage their condition. The top ﬁve thera-
pies used for crLBP during a patient’s lifetime were phy-
siotherapy, osteopathic treatment, exercise therapy,
opioids, and therapeutic massage. Study participants had
used on average 6.5 therapies to manage their crLBP
during their life. The use of physiotherapy was signiﬁ-
cantly associated with longer pain duration; osteopathic
treatment was associated with age under 75 years, female
gender, higher education, and CM insurance coverage.
Exercise therapy was associated with non-smoking and
longer pain duration. The PCPs’ age and gender were not
associated with the use of speciﬁc crLBP treatments.
Patients of PCPs who were trained in CM wereT
ab
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signiﬁcantly less likely to have used opioids for crLBP.
Regarding communication, about a half of participants
reported that their PCP did not enquire about their
CM use.
It is difﬁcult to ﬁnd reliable comparative ﬁgures of
crLBP treatment use. First, there is a paucity of studies
on treatment use that includes both conventional and CM
for crLBP. Second, existing estimates vary greatly,
depending on clinical setting, period of observation, and
CM deﬁnition. Osteopathic treatment and therapeutic mas-
sage were also among the most commonly used CM in
another study in the same city and in an integrative review
involving several countries (Australia, Belgium, Canada,
Denmark, Germany, UK, and USA).26,40 Lifetime CM use
for crLBP was higher in our study (86.6%) than in a study
conducted in a tertiary spine orthopedic clinic in Hong
Kong (72.3%).41 We also found a higher occurrence of
CM use than that found in a pain center in Switzerland
(77.3%).26 Our observation that those with crLBP often
seek several different treatment options is consistent with
the literature.26,40,42,43 Patients and their PCPs had differ-
ent opinions when rating the usefulness of opioids:
patients ranked opioids in second rank (among 11), while
their PCPs ranked opioids after the tenth position (among
25 therapies).
Although previous studies reported that female gender,
younger age, and higher education were associated with
the use of CM therapies,25,44 among the therapies used by
>20% of participants, these three predictors were asso-
ciated only with osteopathic treatment.
We observed that the lack of coverage of some thera-
pies by the mandatory basic health insurance in
Switzerland did not prevent participants from using them.
Indeed, some therapies excluded from basic health insur-
ance coverage are among the most used, for example,
osteopathic therapy and therapeutic massage. This might
suggest that patients are satisﬁed with these therapies and
willing to access them by signing up for supplemental CM
insurance coverage or by paying out of pocket. Another
explanation could be that having a supplemental insurance
coverage for CM therapies could also be a reason why
patients resort to CM in ﬁrst place. Participants with CM
insurance coverage were more likely to use chiropractic
and osteopathic therapies, which seems surprising because
chiropractic treatment is reimbursed by mandatory basic
health insurance. One explanation is that patients who
underwent osteopathic treatment might also have turned
to chiropractic because it is covered by the basic health
insurance scheme. However, the temporal sequence of the
use of various treatments is not known in the present
study.
Regarding PCP prescription practices in individuals
presenting with crLBP, previous studies found that the
gender of the treating practitioner inﬂuenced pain manage-
ment practices for the treatment of back pain, which does
not seem to be the case in our study.45,46 However, the link
between PCPs’ age and gender and their referral patterns
is not always clear in the literature.38,47 In our study, half
of the participants indicated that their PCP inquired about
CM use, whereas two-thirds of CM users told their PCP
about it, which is consistent with previous ﬁndings in
Switzerland.26 In the Hong Kong study, only one-third of
CM users informed their PCPs of such use41 and the same
proportion was obtained in the meta-analysis of disclosure
rate for biologically-based CM.30 However, this meta-ana-
lysis was not focused on crLBP and included a large
variety of populations and indications.
In primary care, the patient–PCP partnership and com-
munication are of prime importance in the management of
crLBP.48–50 An effective partnership between patients and
PCPs may improve patients’ self-ability to manage their
pain and could improve patients’ health outcomes particu-
larly with the growing acceptation of the concept of
patient-centered care in health-care services.50,51 Studies
on nondisclosure of CM use consistently mention three
main reasons for patients not informing their PCP:52 fear
of a negative reaction from the PCP, the view that the PCP
does not need to know about patient CM use and does not
know much about CM, and the PCP not asking about CM
use.30 PCPs should address the question of CM use with
their patients more systematically.23 Physicians specialized
in integrative and complementary medicine could help
inform and guide PCPs and patients with crLBP about
the most effective CM treatment options, their potential
interactions with conventional therapies, and their side
effects. PCPs should open the dialogue with their patients
to inform them about effective care options and to estab-
lish together shared decision making about crLBP
management.
In practice, crLBP patients use a wide range of treat-
ments to manage their condition. Although the high fre-
quency of use and perceived beneﬁt of osteopathic therapy
and therapeutic massage seem to be in accordance with
rising evidence about the beneﬁt of these therapies in the
context of LBP,53,54 our results underline the fact that use of
care is not systematically in accordance with the best
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currently available evidence. Indeed, therapies lacking evi-
dence of effectiveness for crLBP may be overused, such as
homeopathy or the frequent use of opioids to treat severe
forms of crLBP, despite recent data showing no additional
beneﬁt of opioids relative to non-opioid medication.11
Conversely, treatment options may be underused, such as
acupuncture, yoga and mindfulness-based stress reduction,
as recent data showed a small to moderate effect, with yoga
having the lowest quality of evidence.16,23 The guidelines of
the American College of Physicians,23 which have provided
a recent assessment of effective noninvasive treatments for
crLBP (involving both CM and conventional therapies)
could be an important tool in improving PCPs’ knowledge
about effective treatments.
Among the limitations of our study, the use of
crLBP-related care during a lifetime is prone to recall
bias. Patients with crLBP may have preferentially indi-
cated treatments used to alleviate acute episodes of LBP
(in particular self-prescribed therapies). In addition,
patients actively involved in their crLBP management
may have participated more readily than less concerned
patients. This potential selection bias might have led to
an overestimation of the total number of therapies used.
The high proportion of CM options in the questionnaire
could also have led to an overestimation of CM use in
comparison with conventional treatments (by drawing
the patients’ attention to their past CM use). Because the
participation rate was limited (33%), and the study did
not have any comparison data about nonparticipants, the
results of this study might not be generalizable. Despite
the adjustment for education level and CM insurance
coverage in multivariate analyses, we cannot exclude
residual confounding by the ﬁnancial situation of
patients.55 We did not inquire about some pain medica-
tions, like the use of acetaminophen or NSAIDs. Such
medication being the most prescribed and over-the-
counter therapy used overall,56 we did not think that it
was relevant to assess its lifetime use, which would
certainly reach 100%. However, it could have inﬂuenced
the ranking of our results concerning the most often
used therapies. Our study focused on the prevalence of
lifetime use of crLBP treatments and not the therapies
used during the previous year only; such a measurement
would have shown fewer treatment users. Neither did
we ask questions about the frequency of use of each
therapy. Another limitation is the lack of information
about the exact circumstances in which patients used the
mentioned therapies, notably how the LBP episodes
were treated. The comparison between the perceptions
of PCPs and patients regarding usefulness should be
interpreted with great caution because the denominators
differed (patients only rated the usefulness of therapies
they had used, while physicians rated the usefulness of
25 therapies).
The study strengths include the use of a detailed and
relatively comprehensive list of various treatment options,
including crLBP treatments requiring no medical prescrip-
tion, that is, data not available in routine statistics. In
addition, we collected data about both the patients and
their PCPs. Moreover, the choice of a private-practice-
based study design is appropriate because, according to
the literature, exclusive CM use for back pain is rare and
those who experience back pain use CM alongside con-
ventional medical therapies.40
Conclusion
Patients visiting their PCP used a wide range of treat-
ments, including conventional and CM therapies for
crLBP, and almost half of them did not have the opportu-
nity to discuss these options with their PCP. This study did
not reveal an obvious pattern between treatment use and
factors such as age, education level and gender of partici-
pants. Equipped with this information, PCPs should routi-
nely inquire their patients about their treatment use for
their crLBP, including CM.
Abbreviation list
CM, complementary medicine; CrLBP, chronic or recur-
rent low back pain; ICC, intraclass correlation coefﬁcient;
LBP, low back pain; PCP, primary care physician.
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